Enabling People to Overcome Foot Ulcer Through Self-Care: Varco® Leg Care Launches First-of-its-Kind Ulcer Treatment Product

Varco®  Leg Care,  a leading Indian consumer health-tech company at the forefront of best-in-class science, phyto-technology and neural netw...

Varco® Leg Care, a leading Indian consumer health-tech company at the forefront of best-in-class science, phyto-technology and neural network innovation for comprehensively addressing leg health issues, has announced the launch of its new flagship product - ‘Ulsr Soothe Max’ – curated dedicatedly for treatment and cure of foot ulcer. Formulated with Varco®’s Phyto Transdermal Technology™, the product stands out as a first-of-its-kind, revolutionary solution globally, with the potential to enable complete healing and recovery of individuals from foot ulcers (including varicose veins ulcer and diabetic foot ulcer) and related concerns such as foot blisters, calluses and corns, et al. 

Of late, both in India and across other parts of the world, infections attributed to diabetic foot ulcer (DFU) are increasingly becoming one of the major causes for hospitalization amongst diabetics. Studies have shown that roughly one in four diabetes patients have the likelihood of developing foot ulcer during their lifetime. Clinical data further suggests that nearly 50 per cent of foot ulcer cases can lead to infections if not treated in time, with up to 20 per cent infections necessitating amputation of leg. Besides diabetes, other significant factors that could increase one’s risk of getting foot ulcer include: varicose veins (causing poor blood circulation in feet), nerve damage in the feet, foot deformities, among others. 

Ulsr Soothe Max – an FDA-approved, made-in-India topical cream, that represents a fantastic blend of nature’s healing touch and advanced scientific innovation, is Varco® Leg Care’s attempt to mitigate the growing public health burden caused by foot ulcer, while simultaneously redefining existing foot ulcer treatment methodologies and processes worldwide. The product introduces a novel dimension in terms of effective foot ulcer treatment, since it can be bought directly by the consumers without requiring a doctor’s prescription, and self-administered by applying it on and around the skin’s surface wherein the ulcer formation has occurred. It has been clinically tested and proven to be efficacious in managing various stages of foot ulcers and allied symptoms, until the penultimate (second last) stage. Depending on the stage of the ulcer, the product, when used regularly, is able to produce optimal positive results for a foot ulcer patient roughly between 4 to 16 weeks’ time period. 

Speaking about the new product launch, Mr. Anondeep Ganguly, CEO, Varco® Leg Care says, “After doing relentless in-house clinical research and trials for nearly one-and-a-half years, we at Varco® Leg Care are delighted and proud to introduce our disruptive foot ulcer treatment product, Ulsr Soothe Max. Powered by our innovative phytotransdermal technology, this is a first-of-its-kind, breakthrough formulation in India and the globe, consisting the soothing and healing properties of plant molecule extracts, along with a proprietary transdermal carrier. The various active ingredients of this product work synergistically at the cellular level, in a bid to enhance circulation and protein delivery, fight bacteria and balance skin microbiome, repair and regenerate skin tissue, and most importantly, deliver targeted relief and recovery to those suffering from venous ulcers or diabetic foot ulcers.”

“We are confident that our new ulcer treatment product, combined with the powerful self-diagnosis capabilities of Varco®’s Neural Network technology, shall prove to be a game-changer in the management of nearly all kinds of foot ulcers, by empowering patients to make informed decisions and achieve ulcer wound healing independently, from the comfort and convenience of their homes. This is turn shall contribute meaningfully to the comprehensive, end-to-end range of leg care solutions’ portfolio that we at Varco® are attempting to build, in line with our mission and vision of delivering healthier legs to everyone,” adds Mr. Anondeep Ganguly.  

Besides, with the aid of its state-of-the-art neural network technology, Varco® Leg Care is offering patients the ability to actively self-diagnose and find out about their current stage of foot ulcer, and determine the exact time needed to achieve complete healing and recovery. Additionally, the company is deploying a lot of automation, technology and content with the aim to improve treatment adherence for its users. This signifies a paradigm shift in the modern-day approach to foot ulcer treatment, empowering people to move away from the traditional ‘wound care’ approach (use of compression, dressings, bandages, etc.) towards largely a ‘self-care’ approach in dealing with their foot ulcer issues. 

Notably, Varco® Leg Care’s pioneering use of proprietary Phyto Transdermal Technology™ allows them to deliver beneficial phyto-venoactive compounds (which support and accelerate healing) in a precise and effective manner to the site of varicose veins and ulcers, which optimizes the therapeutic impact. The transdermal technology is responsible for enhanced absorption, which means the formulation can seamlessly penetrate onto the deepest layers of the skin tissue and then make its way onto the bloodstream in only a few minutes after applying the product, thereby maximizing its benefits and impact. Varco®’s embrace of the Phyto Transdermal Technology™ also aligns with the company’s broader commitment towards advancing sustainability, eco-consciousness, and bringing nature-inspired solutions to the fore. 

As a ‘digital-first’ consumer healthcare brand, post the product launch, they will initially focus on garnering traction for the newly-introduced topical ulcer treatment product through various online channels, including Varco®’s official website (visit https://varcolegcare.com/products/ulsr-soothe-max for more details) and various marketplaces like Amazon, Flipkart, 1MG, and others. Backed by their strong clinical research lineage spanning more than three decades, Varco® Leg Care has been introducing various consumer-centric products and solutions. In the near future, the company has plans to unveil a few more quintessential topical phyto-products catering to other serious leg health issues such as restless leg syndrome, nail fungus, and cellulite.­ With innovative use of cutting-edge neural network technology and plant molecule technology, Varco® Leg Care offers users the ability to actively self-diagnose and manage their leg health, ushering in a new era of personalized care and convenience.